Skip to content

Lumexa Imaging Holdings, Inc. LMRI Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

RadNet logo
RadNetRDNT
Quest Diagnostics logo
Quest DiagnosticsDGX
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$252.5M+3.1%
Operating income$19.4M-24.0%
Net income$1.7M+122%
EPS (diluted)$0.02+118%

Balance sheet

See full
Cash & equivalents$51.2M
Total debt$965.8M
Total equity$599.6M+272%
Total assets$1.8B

Cash flow

See full
Operating cash flow$2.9M+121%
CapEx$5.3M+431%
Free cash flow-$2.4M+84.1%

Valuation

See full
Market cap$1.02B-42.0%
Enterprise value$1.93B

Returns & leverage

See full
Debt / equity1.6×
Current ratio1.4×

Where this comes from

Reported directly by Lumexa Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Lumexa Imaging Holdings, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lumexa Imaging Holdings, Inc. 's equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lumexa Imaging Holdings, Inc. 's equity method investments (note 11)?
Lumexa Imaging Holdings, Inc. (LMRI) reported equity method investments (note 11) of $420.52M in Q1 2026.